The immune response of a formalin-inactivated alum-precipitated fowl cholera vaccine (FCV) was evaluated in quails, Coturnix japonica (Order: Galliformes and Family: Mimidae). All quails, irrespective of sex and 8-weeks-old were immunized with 5×10 7 CFU/ml/quail subcutaneously (SC) and intramuscularly (IM). A Booster immunization was given with similar dose and routes at 15 days after primary immunization in groups A and B while group C served as unimmunized control. Pre-immunized sera were collected from all groups of birds to assay the primary antibody levels in them. Sera of the immunized and control quails were collected at 15 and 30 days post immunization. The degree of immunity produced in each group of quails following primary and secondary immunizations were determined by measuring their serum antibody titres using passive haemagglutination assay (PHA) test. The level of antibody was significantly increased both primary and booster immunization in immunized quails as determined by PHA titres. Two weeks after final immunization, the quails were challenged with a virulent isolate of fowl cholera and immunized quails conferred 100% protection while all the control quails were dead within 10 days post challenge.
Introduction
Fowl cholera (FC) is one of the most important contagious bacterial diseases of poultry caused by the bacterium Pasteurella multocida. It occurs sporadically or enzootically in most countries of the world including Bangladesh (Heddleston & Rhoades, 1978; Choudhury et al., 1985) . Most reported outbreaks of FC are in chickens, turkeys, ducks, geese and also in quails (Heddleston and Watko, 1965; Choudhury et al., 1985) . FC typically occurs as a fulminating disease with massive bacteraemia and high morbidity and mortality. Vaccination is practiced as preventive measures in Bangladesh like in other countries of the world to reduce the incidence of the disease . Both humoral and cell mediated immunity are considered to be of primary importance in the protection of animals and birds against infectious diseases (Collins, 1977; Mondal et al., 1988) . The immune responses (Mondal et al., 1988; Choudhury et al., 1990) , efficacy of oil adjuvanted broth culture (Choudhury et al. 1987) , alum-precipitated vaccines (Khan et al., 1994; Islam et al., 2004) and comparative efficacy of different FCV have been evaluated under local conditions. But vaccination has not yet been practiced in quail against FC. Quail is reported to be more resistant to many infections as reported earlier (Heddleston & Rhoades, 1978) but presently there are many unpublished reports from farmers of the incidence of FC like infection in quail. Although various studies have been conducted on the FC in experiment models (Islam et al., 2004) , but there is no available information regarding the immune responses against FC vaccine in this bird. The present research therefore was conducted to determine the efficacy and safety level of alum-precipitated FCV with their immunogenic response in quail.
Materials and Methods
A total of 30 eight-week-old quails Coturnix japonica (Galliformes:Mimidae) used for this study were purchased from the Bangladesh Agricultural University (BAU) poultry farm, Mymensingh.
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These quails were reared in the poultry shed of the Department of Microbiology and Hygiene, BAU, Mymensingh supplying food and water ad libidum with maintaining proper biosecurity. Pasteurella multocida (PM-38) serotype 1(X-73) was collected from the same Department and used for the preparation of formalin killed alumprecipitated FCV as well as challenge virulent organisms. The quails were equally divided into three experimental groups namely A, B, and C and were maintained in separate cages. Each of the quails of A and B groups was immunized with 0.5 ml of 5×10 7 CFU of the FCV through subcutaneous (SC) and intramuscular (IM) route, respectively.
Booster immunization was administered in A and B groups after 15 days of primary immunization. Quails of the group C served as unimmunized control throughout the experimental period.
The immune response was studied by using passive haemagglutination assay (PHA) and protection tests to determine the presence of antibody against P. multocida in the serum of quails immunized with the prepared FCV. PHA test was conducted according to the procedure described by Tripathy et al. (1970) and Islam et al. (2004) . The protection test was conducted on both immunized and control groups of quails with the same dose rate mentioned above through IM route as described by Choudhury et al. (1985) and Islam et al. (2004) . The challenged quails were observed up to 10 days for the development of any clinical signs and symptoms of FC. P. multocida was reisolated from challenged quails according to the method of Choudhury et al. (1987) . Statistical significance was evaluated using student ' t test. All the analyses were performed using SPSS (10.0 version). A p-value of <0.05 being considered as statistically significant.
Results and Discussion

PHA test:
The test was conducted to determine the immune response induced in quails having been inoculated to 8-week-old quails with the antigen containing P. multocida. In this respect, Choudhury et al. (1985) ; Chang (1987) ; Mondal et al. (1988) and Sarker et al. (1992) stated that PHA test was useful for assay the serum antibody titres following administration of FC vaccine. The mean antibody titres of quails of group A and B were 51.2±16.52 and 57.6±29.4, respectively after primary immunization which is similar to the findings of Coates et al. (1977) and Mondal et al. (1988) whereas the mean antibody titres were 102.4±33.05 in both groups of quails after booster immunization which corresponds with the findings of Choudhury et al. (1987) and Mondal et al. (1988) . The mean pre-vaccination PHA titre of sera samples of all immunized and control quails were found to be 4±0, which correlated with finding of Mondal et al. (1988) (Fig. 1) . Protection test: Quails of groups A and B showed 100% protection against challenge infection whereas quails of the group C showed 0% protection (Fig. 2) . Immunized quails protected challenge infection showed no clinical signs except for dullness, depression and drowsiness. In controls, the clinical signs first observed at 12 hours post inoculation (PI) were characterized by dullness and depression. There were dullness, depression, slight rise of body temperature (42.5°C) and increased respiratory rates (30-45/min) at 24 hours PI. At 48 hours PI, severe weakness, drowsiness, anorexia, rise of body temperature (43.6°C), increased respiratory rates (45-55/min), lameness and whitish (chalky) diarrhoea with mucous were the important clinical manifestations which was previously observed by many authors' (Sharma et al. 1974; Gordon and Jordan, 1985; Rhoades and Rimler, 1990) . The clinical signs at 96 hours PI were almost similar to that of 48 hours. Death of one quail was observed first at 24 hours PI, while two died at 48 hours and others died at 96 hours PI.
Post challenge isolation of bacteria: P. multocida were reisolated from heart, blood, liver and brain of quails of all groups. Therefore, it may be suggested the formalin killed alum-precipitated FCV prepared with highly antigenic strain of P. multocida should be used to provide better protection against the epidemic FC in quail. However, further study with large number of quails to determine the efficacy of routes of immunization and establishment of Enzyme linked immunosorbent assay test instead of PHA for determination of immune response is necessary to conclude about the present study.
